Items in FPM with MESH term: Physician's Practice Patterns

Pages: Previous 1 2 3 4 5 6 7 8 Next

Delaying Antibiotics for Respiratory Infections - Cochrane for Clinicians

Antibiotics for Acute Laryngitis in Adults - Cochrane for Clinicians

Physicians Who Do Not Follow Screening Guidelines - Curbside Consultation

The More Things Change - Opinion

Evaluating the Safety and Effectiveness of New Drugs - Article

ABSTRACT: Prescribers seek to provide their patients with access to the latest innovations in medicine to maximize their health status. When a new drug comes to market, it often has not been as widely tested as other available therapies, and its effectiveness and safety cannot be fully evaluated. To address this problem, physicians can use the STEPS (Safety, Tolerability, Effectiveness, Price, and Simplicity) mnemonic to provide an analytic framework for making better decisions about a new drug’s appropriate place in therapy. A key element is to base this evaluation on patientoriented evidence rather than accept disease-oriented evidence (which may be misleading), while avoiding inappropriate reliance on studies that report only noninferiority results or relative risk reductions. The primary question to ask for each new drug prescribing decision is, “Is there good evidence that this new drug is likely to make my patient live longer or better compared with the available alternatives?” (Am Fam Physician. 2010;82(1):53-57. Copyright © 2010 American Academy of Family Physicians.)

Should Your Practice Participate in a Quality-Reporting Program? - Feature

Evidence for Global CHD Risk Calculation: Risk Assessment Alone Does Not Change Outcomes - Editorials

Five Signs You May Have Joined the Wrong Practice - The Last Word

Prescribing Evidence: The Effectiveness and Safety of New Drugs - Editorials

How Inclusive Leadership Can Help Your Practice Adapt to Change - Feature

Pages: Previous 1 2 3 4 5 6 7 8 Next


Information From Industry